Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
Imatinib in combination with anti-CD47 exerts synergetic anti-leukemia effect in chronic myeloid leukemia
تأثير دمج الايمتينيب مع anti-CD47 على خلايا سرطان الدم النخاعي المزمن
Subject
:
Faculty of Science
Document Language
:
Arabic
Abstract
:
Chronic myeloid leukemia is cancer that characterized by myeloid cells accumulation in peripheral circulation and unregulated bone marrow development. Imatinib Mesylate -5mg- is considered as the first line of treatment. Cancer immunotherapy such as monoclonal antibody currently offer a better option with less toxicity comparing to small molecules treatment. One of the fundamental features of cancer cells is immune evasion. Immune evasion occurs when CD47 -a transmembrane protein- that binds to SIRP-alpha and release (don’t eat me signal). Cancer cells utilize from this interaction to grow uncontrollably. Blocking CD47 with monoclonal antibody will enable immune system to recognize and destroy cancer cells. Reducing this dose without effecting the treatment efficacy was conducted by combining lower dose of IM with anti-CD47mAb clone BRIC126. Blast CML K562 cell line was used in the study. Cells were cultured and divided into 6 groups including (control group-BRIC126-5µM and 2.5µM of imatinib). Then levels of (GAB-2, SHC-1, PTPN6) which are proteins that implicated in cell signaling pathways was measured through ELISA. As well as CYQUANT cell proliferation assay to determine the amount of DNA and the ability of cells to proliferate after the treatment. Results indicated that with lowering the dose of IM by half and combining it with BRIC126, cells are proceeding to apoptotic pathways. Additionally, proliferation rate was controlled in all studied groups. In vitro findings indicated that this combination may be successful therapy.
Supervisor
:
Dr. Wesam Abdulaal
Thesis Type
:
Master Thesis
Publishing Year
:
1445 AH
2023 AD
Added Date
:
Wednesday, November 1, 2023
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
بشرى مفرح عسيري
Asiri, Bushra
Researcher
Master
Files
File Name
Type
Description
49480.pdf
pdf
Back To Researches Page